EMEA-000200-PIP01-08-M08

Key facts

Invented name
Onglyza
Active substance
Saxagliptin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0277/2019
PIP number
EMEA-000200-PIP01-08-M08
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of type II diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
AstraZeneca AB

E-mail: paediatrics@astrazeneca.com
Tel. +46 855324400

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating